To The Moon

$Kintara Therapeutics, Inc.(KTRA)$ 

The Kintara Therapeutics Inc. stock price gained 13.68% on the last trading day (Wednesday, 7th Dec 2022), rising from $8.48 to $9.64. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 21.42% from a day low at $8.31 to a day high of $10.09. The price has risen in 8 of the last 10 days and is up by 144.67% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 471 thousand more shares were traded than the day before. In total, 550 thousand shares were bought and sold for approximately $5.30 million.

Here's how to buy KTRA stock if you're new to investing.

The stock has broken the very wide and strong rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at $6.16, a level that may pose a second chance to hit a runner. According to fan-theory $10.42 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

KTRA Signals & Forecast

The Kintara Therapeutics Inc. stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $7.97 and $2.79. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, November 11, 2022, and so far it has risen 11641.92%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Option strategy with 97% accuracy in today’s market* >>>* >>> Ad

Support, Risk & Stop-loss for Kintara Therapeutics Inc. stock

Kintara Therapeutics Inc. finds support from accumulated volume at $9.16 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

$9.16 $9.64

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $1.78 between high and low, or 21.42%. For the last week, the stock has had daily average volatility of 25.97%.

Our recommended stop-loss: $9.31 (-3.42%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from a pivot bottom found 17 days ago.)

Trading Expectations (KTRA) For The Upcoming Trading Day Of Thursday 8th

For the upcoming trading day on Thursday, 8th we expect Kintara Therapeutics Inc. to open at $9.35, and during the day (based on 14 day Average True Range), to move between $8.68 and $10.60, which gives a possible trading interval of +/-$0.96 (+/-10.01%) up or down from last closing price. If Kintara Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 20.01% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $0.480 (4.98%) our system find the risk reward attractive.

Insiders are very positive buying more shares than they are selling in Kintara Therapeutics Inc.

In the last 100 trades there were 14.98 million shares bought and 15.57 thousand shares sold. The last trade was made 129 days ago by Hoffman Robert E. who bough 1.2 million shares. The large amount of stocks bought compared to stocks sold indicate that the insiders believe there is a potential good upside. In some cases larger purchases can be explained by due date for stock options.